EPS for Brookfield Infrastructure Partners L.P. (BIP) Expected At $1.03; Seattle Genetics (SGEN) Has 1.3 Sentiment

October 12, 2017 - By wolcottdaily

Seattle Genetics, Inc. is a biotechnology firm focused on the development and commercialization of therapies for the treatment of cancer. The company has market cap of $8.83 billion. The Firm is engaged in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. It currently has negative earnings. The Company’s marketed product ADCETRIS, or brentuximab vedotin, is an antibody-drug conjugate .

Analysts expect Brookfield Infrastructure Partners L.P. (NYSE:BIP) to report $1.03 EPS on November, 3.They anticipate $0.14 EPS change or 15.73% from last quarter’s $0.89 EPS. T_BIP’s profit would be $378.40M giving it 10.43 P/E if the $1.03 EPS is correct. After having $1.06 EPS previously, Brookfield Infrastructure Partners L.P.’s analysts see -2.83% EPS growth. The stock decreased 0.53% or $0.23 on October 12, reaching $42.98. About 163,848 shares traded. Brookfield Infrastructure Partners L.P. (NYSE:BIP) has risen 38.95% since October 12, 2016 and is uptrending. It has outperformed by 22.25% the S&P500.

Since January 1, 0001, it had 0 buys, and 3 insider sales for $2.20 million activity.

Baker Bros. Advisors Lp holds 20.68% of its portfolio in Seattle Genetics, Inc. for 45.73 million shares. Lagoda Investment Management L.P. owns 398,529 shares or 7.88% of their US portfolio. Moreover, Ghost Tree Capital Llc has 3.23% invested in the company for 300,000 shares. The California-based Redmile Group Llc has invested 2.09% in the stock. Eventide Asset Management Llc, a Massachusetts-based fund reported 525,000 shares.

About 1.97M shares traded or 80.73% up from the average. Seattle Genetics, Inc. (SGEN) has risen 75.68% since October 12, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.

Analysts await Seattle Genetics, Inc. (NASDAQ:SGEN) to report earnings on October, 26. They expect $-0.42 EPS, down 82.61% or $0.19 from last year’s $-0.23 per share. After $-0.39 actual EPS reported by Seattle Genetics, Inc. for the previous quarter, Wall Street now forecasts 7.69% negative EPS growth.

Ratings analysis reveals 40% of Seattle Genetics’s analysts are positive. Out of 5 Wall Street analysts rating Seattle Genetics, 2 give it “Buy”, 1 “Sell” rating, while 2 recommend “Hold”. SGEN was included in 5 notes of analysts from September 7, 2016. Morgan Stanley initiated the shares of SGEN in report on Wednesday, September 7 with “Overweight” rating. The rating was downgraded by Credit Suisse to “Neutral” on Monday, December 12. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, October 10 report. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Neutral” rating given on Thursday, September 15 by Goldman Sachs. Bank of America downgraded the shares of SGEN in report on Friday, February 10 to “Underperform” rating.

Among 9 analysts covering Brookfield Infrastructure Partners (NYSE:BIP), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Brookfield Infrastructure Partners had 29 analyst reports since August 6, 2015 according to SRatingsIntel. As per Friday, June 9, the company rating was maintained by RBC Capital Markets. The firm has “Neutral” rating given on Monday, September 19 by Citigroup. TD Securities maintained Brookfield Infrastructure Partners L.P. (NYSE:BIP) on Wednesday, March 16 with “Buy” rating. The rating was maintained by Credit Suisse with “Hold” on Friday, September 15. The rating was initiated by National Bank Canada with “Outperform” on Tuesday, December 1. The firm has “Outperform” rating by Raymond James given on Monday, September 26. The firm has “Strong Buy” rating given on Wednesday, January 13 by Raymond James. On Friday, September 8 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by Scotia Capital on Thursday, August 6 with “Sector Perform”. The stock of Brookfield Infrastructure Partners L.P. (NYSE:BIP) has “Hold” rating given on Tuesday, August 22 by Credit Suisse.

Brookfield Infrastructure Partners L.P. owns and operates utilities, transport, energy and communications infrastructure businesses in North and South America, Europe and Asia Pacific. The company has market cap of $15.79 billion. The Company’s divisions include utilities, transport, energy, communications infrastructure and other. It has a 91.52 P/E ratio. The utilities segment consists of regulated businesses, including regulated distribution , electricity transmission and a regulated terminal (coal export terminal).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: